Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve the following: 1. Audited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hindustan Bio Sciences Ltd has informed BSE that its Board of Directors will meet on 30 May 2025 at 2:00 PM at its registered office in Hyderabad. The main items on the agenda are the approval of audited financial results for the quarter and full year ended 31 March 2025, along with the audit report for that period. The Board will also consider appointing a Secretarial Auditor for a five-year term covering FY 2025-26 to FY 2029-30, and the appointment of an internal auditor. Any other business permitted by the Chair may also be taken up. This is a routine regulatory intimation under SEBI LODR Regulation 29(1)(a) ahead of the FY25 results announcement.
Investors should watch for the audited FY25 results announcement post the 30 May board meeting, which could move the stock. The long-term appointment of a Secretarial Auditor is an administrative compliance step and is unlikely to have a direct price impact.